Abstract
The process of trial design in portal hypertension has come a long way since the first Baveno meeting in 1990. Robust, clinically relevant endpoints have been identified and agreed. New priorities in research and clinical management have been prioritized, and hypotheses generated and examined. Nowhere is this better represented than in the management of variceal bleeding, where prognostication is based on hard clinical data as opposed to “feel”, and clinical decision-making is now occurring driven by this evidence base. Some of this evidence is explored below, recognizing that the factors that result in a successful outcome for the patient are multiple, and interconnected.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Pagliaro L, Franchis RD. Where were we. In: Franchis RD, editor. Portal Hypertension 2. Proceedings of The Second Baveno International Consensus Workshop on Definitions, Methadology and Therapeutic Strategies. Oxford: Blackwell Science Ltd; 1996. p. 2.
Garcia-Tsao G, et al. Predictive models in portal hypertension. In: Franchis RD, editor. Portal Hypertension 4. Proceedings of the Fourth Baveno International Consensus Workshop on Methadology of Diagnosis and Treatment. Oxford: Blackwell Publishing; 2006. p. 47–100.
D’Amico G, Licata A, Pasta L, Rizzuto G, D’Amico M, Mocciaro F. Prognostic indicators in cirrhosis: the role of Child classification. Overview of 93 published studies and validation in a prospective cohort of patients. Dig Liver Dis. 2005;37:S(29).
D’Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38(3):599–612.
Villanueva C, O’Beirne J, Bureau C, Tahbut D. A la carte treatment of acute variceal bleeding. In: Franchis RD, editor. Portal Hypertension 6. Proceedings of the SIxth Baveno Consensus Workshop: Stratifying Risk and Individualising Patient Care. Cham: Springer International Publishing; 2016. p. 261–5.
Monescillo A, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology. 2004;40(4):793–801.
García-Pagán JC, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370–9.
Thuluvath PJ, et al. Liver transplantation in patients with multiple organ failures: feasibility and outcomes. J Hepatol. 2018;69(5):1047–56.
Motola-Kuba M, et al. Validation of prognostic scores for clinical outcomes in cirrhotic patients with acute variceal bleeding. Ann Hepatol. 2016;15(6):895–901.
Hermie L, et al. Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage. Eur J Gastroenterol Hepatol. 2018;30(12):1441–6.
Maimone S, et al. Predictors of re-bleeding and mortality among patients with refractory variceal bleeding undergoing salvage transjugular intrahepatic portosystemic shunt (TIPS). Dig Dis Sci. 2019;64(5):1335–45.
Walter A, Rudler M, Olivas P, Moga L, Trépo E, Robic MA, et al. Combination of model for end-stage liver disease and lactate predicts death in patients treated with salvage transjugular intrahepatic portosystemic shunt for refractory variceal bleeding. Hepatology. 2021;74(4):2085–101. https://doi.org/10.1002/hep.31913.
Rudler M, et al. Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding. Liver Int. 2018;38(3):469–76.
D’Amico G, D’Amico M, Malizia G. Refining early-TIPS criteria requires good quality prognostic studies. Liver Int. 2018;38(3):412–4.
Lv Y, et al. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4(8):587–98.
Dunne PDJ, et al. Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding. Aliment Pharmacol Ther. 2020;52(1):98–106.
Lv Y, et al. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study. Gut. 2019;68(7):1297–310.
Sundaram V, et al. Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation. Gastroenterology. 2019;156(5):1381–1391.e3.
McPhail MJ, et al. Increased survival for patients with cirrhosis and organ failure in liver intensive care and validation of the chronic liver failure-sequential organ failure scoring system. Clin Gastroenterol Hepatol. 2015;13(7):1353–1360.e8.
Qi X, et al. Virtual hepatic venous pressure gradient with CT angiography (CHESS 1601): a prospective multicenter study for the noninvasive diagnosis of portal hypertension. Radiology. 2019;290(2):370–7.
Zou Z, et al. von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis. BMJ Open. 2019;9(8):e025656.
Qi X, et al. Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension. Lancet Gastroenterol Hepatol. 2018;3(10):708–19.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this paper
Cite this paper
Patch, D. (2022). Risk Stratification and Prognostic Factors in Variceal Bleeding. In: de Franchis, R. (eds) Portal Hypertension VII. Springer, Cham. https://doi.org/10.1007/978-3-031-08552-9_38
Download citation
DOI: https://doi.org/10.1007/978-3-031-08552-9_38
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-08551-2
Online ISBN: 978-3-031-08552-9
eBook Packages: MedicineMedicine (R0)